BD Selects Torrey View by Breakthrough as San Diego Campus for Growing Biosciences Business

Breakthrough Properties, a global developer of life sciences real estate, formed through a joint venture of Tishman Speyer and Bellco Capital, announced that global medical technology company BD (Becton, Dickinson and Company) has selected Torrey View by Breakthrough as home for an expanded San Diego Reagent Innovation Center for its growing BD Biosciences business.

"We are thrilled to welcome BD Biosciences to Torrey View and the broader Breakthrough family," said Susie Harborth, Executive Vice President for Operations at Breakthrough Properties. "BD is exactly the type of dynamic and fast-growing firm we had in mind when we set out to create this life science campus. We are honored and proud to support a company that plays such a critical role in advancing the world of health."

Puneet Sarin, Worldwide President for BD Biosciences, said, "Our new facility in San Diego will aid in elevating our research, development and operations capabilities and position BD for exciting growth. BD Biosciences is a cornerstone of BD's purpose to advance the world of health, providing researchers with innovative tools that drive a deeper understanding of the immune system and unlock its unique power to fight disease. We are pleased to select the Torrey View by Breakthrough campus to house this dynamic work now and in the future. The campus will accommodate a flexible working environment, support collaboration and innovation, and serve our desire to attract and retain the best talent for years to come."

Torrey View is a 10-acre, world-class life sciences research and development campus that Breakthrough is creating alongside its co-equity partner Mitsui Fudosan America. Strategically located within San Diego's burgeoning Del Mar Heights life sciences cluster and adjacent to biopharma workforce housing, Torrey View will feature three research and development buildings and a tenant clubhouse. BD will lease the campus' largest planned building. At 220,000 square feet, BD Biosciences will occupy more than 40 percent of Torrey View's total available space.

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!

  • <<
  • >>

Join the Discussion